<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebrospinal fluid (CSF) neopterin levels were determined by high-pressure liquid chromatography in 48 <z:mpath ids='MPATH_458'>normal</z:mpath> children and in 15 children with meningeal relapse of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> (13 <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> and 2 high-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>When meningeal relapse was diagnosed, <z:hpo ids='HP_0000001'>all</z:hpo> patients had CSF neopterin levels higher than mean <z:mpath ids='MPATH_458'>normal</z:mpath> value +2 standard deviations </plain></SENT>
<SENT sid="2" pm="."><plain>No significant correlation between the blast count in the CSF and neopterin levels was observed </plain></SENT>
<SENT sid="3" pm="."><plain>CSF data before relapse were available in 10 children: the neopterin values at relapse were significantly higher than values observed at diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>In 3 patients, elevated neopterin levels preceded the occurrence of neurologic signs and the detection of blast cells in CSF by 15 to 30 days </plain></SENT>
<SENT sid="5" pm="."><plain>In the absence of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, the rise of CSF neopterin levels in patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> indicates an active phase of the disease </plain></SENT>
<SENT sid="6" pm="."><plain>This could reflect a cell-mediated immunologic process induced by malignant cells </plain></SENT>
<SENT sid="7" pm="."><plain>The measurement of CSF neopterin should be helpful in the monitoring of patients to detect early meningeal relapse </plain></SENT>
</text></document>